文献速递心脏核医学

使用正电子发射断层显像定量二尖瓣反流

Quantitation of mitral regurgitation using positron emission tomography.
PubMed 文献 · EJNMMI Res · 2024-09-18

本研究纳入21例重度原发性二尖瓣反流患者,同日行动态15O-水和11C-乙酸PET及心脏磁共振(CMR),以指示剂稀释法和门控图像分析计算反流体积(RegVol)与反流分数(RegF)。PET测值与CMR强相关,但存在系统性低估;鉴别中度以上反流体积(>30 mL)的准确率15O-水为95%、11C-乙酸为92%。

要点

  • PET计算的RegVol与CMR强相关:15O-水 r=0.94,11C-乙酸 r=0.91(p<0.001)。
  • PET计算的RegF与CMR强相关:15O-水 r=0.88,11C-乙酸 r=0.84(p<0.001)。
  • PET存在系统性低估:RegVol 15O-水偏差-11±13 mL(p=0.002),11C-乙酸-28±16 mL(p<0.001)。

核心结论

  • 使用心脏PET定量的左心室反流严重程度与CMR相关,并在区分患者与健康志愿者方面显示出高准确率。

研究设计与样本

  • 研究纳入21例重度原发性二尖瓣反流患者,同日行动态15O-水和11C-乙酸PET检查及CMR。
  • PET数据重建为第一通过期短时间帧动态序列、门控15O-水血池图像和门控11C-乙酸心肌摄取图像。
  • 另与18名健康志愿者进行比较。

主要发现

  • PET测得的RegVol与CMR强相关:15O-水 r=0.94,11C-乙酸 r=0.91(p<0.001)。
  • PET测得的RegF与CMR强相关:15O-水 r=0.88,11C-乙酸 r=0.84(p<0.001)。
  • PET存在系统性低估(偏差):RegVol 15O-水 -11±13 mL(p=0.002),11C-乙酸 -28±16 mL(p<0.001);RegF 15O-水 -4±6%(p=0.01),11C-乙酸 -10±7%(p<0.001)。
  • 健康志愿者(n=18)的平均RegVol和RegF均显著低于患者,两种示踪剂结果一致。
  • 诊断中度以上反流体积(>30 mL)的准确率:15O-水为95%,11C-乙酸为92%。

关键数值与推荐

  • 反流体积定量:15O-水 r=0.94,11C-乙酸 r=0.91(与CMR比较,p<0.001)。
  • 反流分数定量:15O-水 r=0.88,11C-乙酸 r=0.84(与CMR比较,p<0.001)。
  • 系统性低估:RegVol 15O-水 -11±13 mL(p=0.002),11C-乙酸 -28±16 mL(p<0.001);RegF 15O-水 -4±6%(p=0.01),11C-乙酸 -10±7%(p<0.001)。
  • 诊断中度以上反流体积(>30 mL)准确率:15O-水95%,11C-乙酸92%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac positron emission tomography (PET) offers non-invasive assessment of perfusion and left ventricular (LV) function from a single dynamic scan. However, no prior assessment of mitral regurgitation severity by PET has been presented. Application of indicator dilution techniques and gated image analyses to PET data enables calculation of forward stroke volume and total LV stroke volume. We aimed to evaluate a combination of these methods for measurement of regurgitant volume (RegVol) and fraction (RegF) using dynamic 15O-water and 11C-acetate PET in comparison to cardiovascular magnetic resonance (CMR). RESULTS: Twenty-one patients with severe primary mitral valve regurgitation underwent same-day dynamic PET examinations (15O-water and 11C-acetate) and CMR. PET data were reconstructed into dynamic series with short time frames during the first pass, gated 15O-water blood pool images, and gated 11C-acetate myocardial uptake images. PET-based RegVol and RegF correlated strongly with CMR (RegVol: 15O-water r = 0.94, 11C-acetate r = 0.91 and RegF: 15O-water r = 0.88, 11C-acetate r = 0.84, p < 0.001). A systematic underestimation (bias) was found for PET (RegVol: 15O-water - 11 ± 13 mL, p = 0.002, 11C-acetate - 28 ± 16 mL, p < 0.001 and RegF: 15O-water - 4 ± 6%, p = 0.01, 11C-acetate - 10 ± 7%, p < 0.001). PET measurements in patients were compared to healthy volunteers (n = 18). Mean RegVol and RegF was significantly lower in healthy volunteers compared to patients for both tracers. The accuracy of diagnosing moderately elevated regurgitant volume (> 30mL) was 95% for 15O-water and 92% for 11C-acetate. CONCLUSIONS: LV regurgitation severity quantified using cardiac PET correlated with CMR and showed high accuracy for discriminating patients from healthy volunteers.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Sigfridsson J, Baron T, Bergsten J, et al. Quantitation of mitral regurgitation using positron emission tomography. EJNMMI Res. 2024. PMID: 39294533. doi:10.1186/s13550-024-01150-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。